Search For "ella"
Kerala to sign agreement for filling Sputnik V doses in vials, planning R
Updated : 4 years, 8 months ago IST
Thiruvananthapuram (Kerala) [India], July 22 (ANI): Kerala is all set to sign an agreement with the Russian Direct Investment Fund (RDIF), the nodal agency for Russian-made Sputnik vaccine, to set up a unit for filling COVID-19 vaccines vials.
Read More
Bharat Biotech releases Phase 3 trial results of Covaxin, claims vaccine e
Updated : 4 years, 8 months ago IST
Hyderabad (Telangana) [India], July 3 (ANI): Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial claiming it to be 77.8 per cent effective against COVID-19.
Read More
Paediatric trials of Covaxin may begin in June
Updated : 4 years, 10 months ago IST
Hyderabad (Telangana) [India], May 24 (ANI): Bharat Biotech may begin paediatric trials of its Covid-19 vaccine Covaxin from June, said the company's Business Development and International Advocacy Head Dr Raches Ella on Sunday.
Read More
Bharat Biotech MD questions experts' silence over UK trials of Covid-19 va
Updated : 5 years, 2 months ago IST
New Delhi [India], January 4 (ANI): Coming down heavily on critics expressing doubts about the Bharat Biotech's indigenously developed coronavirus vaccine COVAXIN, the Hyderabad-based biotech major's managing director Dr Krishna Ella on Monday slammed the critics for targeting Indian clinica
Read More
Our goal is to provide global access of Covaxin to needy population: Dr E
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], January 4 (ANI): The emergency use approval for Covaxin is "a giant leap for innovation and novel product development" in India and the "goal is to provide global access to populations that need it the most", Bharat Biotech chairman and managing director Dr
Read More
Covaxin is 200% safe, says Bharat Biotech Chairman
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], January 4 (ANI): Covaxin, the indigenous vaccine developed by Bharat Biotech against COVID-19 in collaboration with ICMR, is 200 per cent safe, company's Chairman and Managing Director Dr Krishna Ella has said and noted that it has shown less than 10 per cen
Read More
Indian companies do not deserve this backlash, Covaxin is simple two doses
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], January 4 (ANI): Bharat Biotech Chairman and Managing Director Dr Krishna Ella said on Monday that the company has tremendous experience in vaccines, takes science seriously and Covaxin is simple two doses.
Read More
COVID-19: Bharat Biotech recruits 23,000 volunteers for COVAXIN's phase 3
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], January 2 (ANI): Bharat Biotech has recruited 23,000 volunteers so far for the Phase III clinical trials of its COVID-19 vaccine candidate, 'COVAXIN'.
Read More
Vice President discusses status of indigenous vaccine against COVID-19
Updated : 5 years, 3 months ago IST
Hyderabad (Telangana) [India], December 25 (ANI): Bharat Biotech Chairman and Managing Director Dr Krishna Ella and Joint Managing Director Suchitra Ella called on the Vice President M Venkaiah Naidu in Hyderabad on Friday.
Read More
Bharat Biotech bosses discuss Covaxin status with Vice-President
Updated : 5 years, 3 months ago IST
Hyderabad (Telangana) [India], December 25 (ANI): Bharat Biotech Chairman and Managing Director Dr Krishna Ella and Joint Managing Director Suchitra Ella called on Vice-President M Venkaiah Naidu at his residence on Friday in Hyderabad.
Read More
In a first, UK court rules air pollution as cause of 9-year-old girl's dea
Updated : 5 years, 3 months ago IST
London [UK], December 17 (ANI): In a landmark judgement, a UK coroner has said that air pollution was the cause of death of a 9-year-old London schoolgirl Ella Kissi-Debrah.
Read More
Covaxin to be available in the first quarter of next year, says Bharat Bio
Updated : 5 years, 3 months ago IST
Hyderabad (Telangana) [India], December 9 (ANI): Covaxin, a vaccine for COVID-19, will be available in the first quarter of next year, said Suchitra Ella, joint managing director of Bharat Biotech on Wednesday.
Read More